New FDA-approved RSV shot for babies and CDC's ACIP meeting recap with Sandra Fryhofer, MD скачать в хорошем качестве

New FDA-approved RSV shot for babies and CDC's ACIP meeting recap with Sandra Fryhofer, MD

The CDC’s Advisory Committee on Immunization Practices (ACIP) recommended a new monoclonal antibody shot that can protect babies from RSV. The AMA’s ACIP liaison, Sandra Fryhofer, MD, joins to discuss the recommendation and details of the shot, including who should get it, how often and what the side effects are. American Medical Association CXO Todd Unger hosts. 🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew 00:00 AMA Update for August 10, 2023 00:42 RSV monoclonal antibody for babies approved by FDA (AstraZeneca, Sanofi) 01:27 Is RSV the leading cause of hospitalization in infants? 01:30 RSV symptoms in babies 01:47 Is RSV fatal in infants? 01:54 RSV hospitalization rates: What percentage of babies get RSV? 02:48 RSV monoclonal antibodies for infants and neonates 03:06 RSV seasons 03:20 RSV injection for infants approved by FDA (toddlers, children up to 24 months) 03:35 Nirsevimab recommended for babies under 8 months 03:51 RSV prevention for infants 8-19 months old 04:21 Protective dose recommended for babies' second RSV season 04:42 RSV prevention shot for babies with cystic fibrosis and severe lung disease 04:55 RSV in immunocompromised and Indigenous American children (American Indian, Alaska Native) 05:29 FDA approved Beyfortus (clinical trials, study data) 05:56 Efficacy of Beyfortus (nirsevimab efficacy) 06:30 RSV shot side effects (adverse reactions, #VAERS) 07:19 RSV treatment cost 07:47 RSV shot doses for babies 08:50 RSV immunizations: RSV vaccine vs monoclonal antibodies (induced vs passive immunity) 09:56 RSV in adults 10:07 FDA approved RSV vaccines for adults (ACIP Shared Clinical Decision-Making Recommendation) 10:30 Risk of severe RSV in older adults (COPD, asthma, heart disease, diabetes, etc.) 10:58 RSV vaccines during pregnancy 11:14 Palivizumab: Synagis cost, dose, effectiveness 11:46 Beyfortus price: Is nirsevimab covered by health insurance or ACA? 12:26 #CDC recommended nirsevimab for Vaccines for Children (VFC program) 12:51 Is nirsevimab effective against RSV? (Respiratory Syncytial Virus hospitalizations, lower respiratory tract infections) Visit the AMA Update video page for more videos in this series: https://www.ama-assn.org/ama-update-v.... — 📺 Follow the AMA on YouTube: @americanmedicalassociation 🎥 Watch #AMAUpdate for the latest in health care news for physicians: https://bit.ly/AMA_Update 📧 Subscribe to AMA Morning Rounds newsletter, with the news you need every morning delivered to your inbox: https://bit.ly/AMA-MorningRounds 🎧 Listen to our latest podcast episodes now: https://bit.ly/AMA_Podcasts 📲 Download AMA Connect for news, podcasts, video updates and learning in one place: https://apple.co/3URzNES #fightingfordocs #medicine #futureofhealthcare #healthcare #medical #science #medicalresearch #vaccines #vaccination #immunization #FDA #CDC #ACIP #RSV #RSVvaccine #RSVtreatment #RSVseason #RespiratorySyncytialVirus #Beyfortus #Nirsevimab #pediatrics #newborns #infants #toddlers #pediatricvaccines